Skip to content

Drug interactions

Danicopan + Nilotinib

Severity: Moderate

Danicopan and Nilotinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Danicopan inhibits P-glycoprotein and may raise concentrations of nilotinib, which is a P-gp substrate. Greater nilotinib exposure raises concerns about QT prolongation.

What this interaction means in plain words

Danicopan and Nilotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Danicopan belongs to Miscellaneous; Nilotinib belongs to Oncology.

Evidence level: Low

Why it happens

P-gp inhibition by danicopan increases nilotinib absorption and exposure.

What to do

Obtain a baseline ECG and monitor ECG and electrolytes during coadministration. Consider reducing the nilotinib dose if toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Danicopan and Nilotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Danicopan with Nilotinib?

MediHelp rates the interaction as moderate. Danicopan and Nilotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Danicopan inhibits P-glycoprotein and may raise concentrations of nilotinib, which is a P-gp substrate. Greater nilotinib exposure raises concerns about QT prolongation.

How serious is the interaction between Danicopan and Nilotinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor ECG and electrolytes during coadministration. Consider reducing the nilotinib dose if toxicity develops.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in